Device-specific quality of life: results from the ATLAS trial—avoid transvenous leads in appropriate subjects.
Aims Patient-reported outcomes (PROs) provide important insights into patients' acceptance of their medical devices. Avoid Transvenous Leads in Appropriate Subjects (ATLAS), a randomized, multi-centre, open-label clinical trial, recently reported fewer perioperative complications in subcutaneous imp...
| Publicado en: | European Journal of Cardiovascular Nursing Vol. 23; no. 8; pp. 877 - 886 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | pictorial research tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
Nov2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |